A Hybrid Approach to Decentralized Trials
Featured in Clinical Researcher: Scott Gray, CEO discusses the importance of a hybrid approach to decentralized trials for patients with rare diseases.
A Hybrid Approach to Decentralized Trials Read More »
Featured in Clinical Researcher: Scott Gray, CEO discusses the importance of a hybrid approach to decentralized trials for patients with rare diseases.
A Hybrid Approach to Decentralized Trials Read More »
Featured on CenterWatch.com: Newly published results from a survey, conducted by the patient support service company Clincierge, found that 95 percent of the trial participants responded and 98 percent of their caregivers considered it essential to have a single point of contact to help them throughout a trial, especially when arranging travel plans.
Rare Disease Trial Participants Need Extra Support and Assistance, Survey Shows Read More »
PHILADELPHIA and SAN DIEGO, June 14, 2022 /PRNewswire/ — Clincierge today released “Voice of the Patient,” a research report examining the patient experience in clinical trials of rare diseases, at the 2022 BIO International Convention in San Diego, California.
Clincierge Releases Study on Patient Experience in Clinical Trials Read More »
Featured in Drug Discovery World: DDW’s Reece Armstrong speaks to Scott Gray, President & CEO of Clincierge about its unique approach to improving the clinical trial experience for patients.
The Company Bringing Patients to Clinical Trials Read More »
During BIO International, a group of industry experts discussed patient recruitment and retention challenges in the panel discussion Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials on Monday, June 13. Outsourcing-Pharma spoke with Clincierge CEO Scott Gray, the moderator of the talk, to get a sneak peek at the session.
BIO Panel Takes on Patient Recruitment, Retention Challenges Read More »
Featured in The Science Advisory Board: Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have a limited pool of patients, contends Clincierge CEO Scott Gray. At the 2022 Biotechnology Innovation Organization (BIO) International Convention, Clincierge will release the results of an independent, institutional review
The ‘Voice of the Patient’ Needs to be Heard in Clinical Trials: Study Read More »
PHILADELPHIA, June 2, 2022 /PRNewswire/ — Clincierge today announced CEO Scott Gray will moderate Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials at the upcoming 2022 BIO International Convention on June 13-16, 2022, in San Diego, California.
Clincierge to Host Patient Experience Panel at BIO International 2022 Read More »
Featured in Applied Clinical Trials, Scott Gray, CEO, discusses how pharmaceutical sponsors and clinical research organizations (CROs) can improve patient retention rates and bolster trial completion with patient-centric trials and patient support services.
The Role of Support Services in Patient Retention Read More »
In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act. This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge,
Are you new to the healthcare industry and want to learn more about clinical trials? Or are you curious about the specifics of patient care during clinical trials? Clinical trials are often complex studies that span multiple years, with a wide variety of professionals taking an active role. This blog breaks down the critical stages
Understanding Clinical Trials: Frequently Asked Questions Read More »